journal article·2026-02

Highly selective small molecular fluorescence probes for detecting α-syn fibrils

Xuefeng Jiang, Ruina Luo, Cenxing Zhou, Xue Tian, Lu Gan, Shizhan Zhang, Yuntao Jia, Xuan Zhai, Biyue Zhu

Dyes and Pigments· Volume 245
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Parkinson's Disease Mechanisms and Treatments · Conducting polymers and applications · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global burden of disease study 202110.1016/S1474-4422(24)00038-3 ↗
2. Prevalence of Parkinson's disease in adults aged 65 years and older in China: a multicenter population-based survey10.1159/000520726 ↗
3. Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021
4. Diagnosis and treatment of parkinson disease10.1001/jama.2019.22360 ↗
5. Parkinson's disease10.1016/S0140-6736(21)00218-X ↗
6. Parkinson's disease10.1016/S0140-6736(14)61393-3 ↗
7. Mutation in the α-Synuclein gene identified in families with Parkinson's disease10.1126/science.276.5321.2045 ↗
8. Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases10.1016/j.neuron.2024.05.006 ↗
9. Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations10.1016/S1474-4422(15)00006-X ↗
10. Characterization of the pathogenic alpha-Synuclein variant V15A in Parkinson s disease10.1038/s41531-023-00584-z ↗
11. Parkinson's disease associated alpha-Synuclein familial mutants promote dopaminergic neuronal death in Drosophila melanogaster10.1021/acschemneuro.8b00107 ↗
12. E46K alpha-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation10.1073/pnas.1703420114 ↗
13. Parkinson's disease associated mutation E46K of alpha-synuclein triggers the formation of a distinct fibril structure10.1038/s41467-020-16386-3 ↗
14. Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease10.1039/D0CS00115E ↗
15. Development and challenge of fluorescent probes for bioimaging applications: from visualization to diagnosis10.1007/s41061-022-00376-8 ↗
16. Detection of oligomers and fibrils of alpha-synuclein by AIEgen with strong fluorescence10.1039/C4CC07911F ↗
17. Novel benzothiazole derivatives as fluorescent probes for detection of beta-amyloid and alpha-Synuclein aggregates10.1021/acschemneuro.6b00450 ↗
18. Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent10.1371/journal.pone.0055031 ↗
19. Design, synthesis, and characterization of 3-(Benzylidene)indolin-2-one derivatives as ligands for alpha-Synuclein fibrils10.1021/acs.jmedchem.5b00571 ↗
20. Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of beta-amyloid deposits10.1021/ja4052922 ↗
21. Novel stilbenes as probes for amyloid plaques10.1021/ja0167147 ↗
22. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease10.1186/s40478-017-0456-2 ↗
23. Specific fluorescent detection of fibrillar alpha-synuclein using mono- and trimethine cyanine dyes10.1016/j.bmc.2007.10.051 ↗
24. Near-infrared fluorescent probes as imaging and Theranostic modalities for amyloid-beta and tau aggregates in alzheimer's disease10.1021/acs.jmedchem.1c01619 ↗
25. Keto form of curcumin derivatives strongly binds to Abeta oligomers but not fibrils10.1016/j.biomaterials.2021.120686 ↗
26. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits10.1021/ja9047043 ↗
27. Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species10.1371/journal.pone.0019362 ↗
28. Curcumin analogues as selective fluorescence imaging probes for brown adipose tissue and monitoring browning
29. Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease10.1021/ja405239v ↗
30. Computational screening of nanoparticles coupling to Abeta40 peptides and fibrils10.1038/s41598-019-52594-8 ↗
31. Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils10.1073/pnas.0806270105 ↗
32. Development of an alpha-synuclein positron emission tomography tracer for imaging synucleinopathies10.1016/j.cell.2023.06.004 ↗
33. Binding adaptability of chemical ligands to polymorphic alpha-synuclein amyloid fibrils10.1073/pnas.2321633121 ↗